Home » Business, Health & Medicine, News & Current Affairs, Pharmaceuticals & Biotech, Science » Hepatitis B Virus Market (HBV) Review with 2016-2025 Forecasts Research Report
“Market Research Reports and Industry Analysis”
OrbisResearch.com has published “Global Hepatitis B Virus (HBV) Market: 10-Year Demand Forecast (2016-2025)” market report to its research database. The report provides an in-depth analysis of the global market along with markets of the US and Europe. The major trends, growth drivers as well as issues being faced by the industry are being presented in this report. Key players listed in the report are Arrowhead, Arbutus, Gilead and Johnson & Johnson.

Hepatitis B is a virus that infects the liver. For most adults who suffer from it for a short time, it is called acute hepatitis B. Sometimes the virus causes a long-term infection which is called chronic hepatitis B. Over time, it can damage the liver. Babies and young children infected with the virus are more likely to get chronic hepatitis B. Abdominal pain, fever, dark urine and joint pain are some of the major symptoms of hepatitis B. Having a chronic HBV may lead to serious implications like liver cancer and liver failure.

Keeping the threat in mind, many governments in the European countries and the US have made it mandatory for the people to go through the screening and proper monitoring since hepatitis B takes time to develop and is not easily recognizable. There are some curative therapies available but they are not very efficient. It is expected that many innovative therapies which have shown positive results in trials will occupy the market in the coming years. Many companies have products related to hepatitis B in their pipeline.

The key factors driving the growth of hepatitis B market are increase in liver cancer and cirrhosis deaths, increasing ageing population, increasing healthcare expenditure and urbanization leading to better monitoring and screening procedures. Some of the noteworthy trends and developments of this industry are new HBV treatments in development, government initiative and public awareness, collaboration, innovation and research, preference for biomarker based tests. However, the expansion of hepatitis B market is hindered by rigid competition, management challenges, lack of diagnostic facilities and high cost of medical care and legal regulations.

The report “Global Hepatitis B Virus (HBV) Market – 10 Year Demand Forecast (2016-2025)” provides an in-depth analysis of the global market along with markets of the US and Europe. The major trends, growth drivers as well as issues being faced by the industry are being presented in this report. The industry comprises large players such as Arrowhead, Arbutus, Gilead and Johnson & Johnson. All these companies have been profiled in the present report highlighting their key financials and business strategies for growth.

Request a sample of this report at http://www.orbisresearch.com/contacts/request-sample/119098 .

Major points from Table of Contents:
1. Market Overview
2. Global HBV Market Analysis
3. Regional Market Analysis
4. Market Dynamics
5. Competitive Landscape
6. Company Profiles

List of Tables:
CHB Treatment Timeline
Global HBV Market Forecast by Value (2016-2025)
The US HBV Market Forecast by Value (2016-2025)
The US Chronic HBV Patients by Volume (2016-2025)
The US Diagnosed HBV Patients Forecast by Volume (2016-2025)
The US Treated HBV Patients Forecast by Volume (2016-2025)
European Union HBV Market Forecast by Value (2016-2025)
European Union Chronic HBV Patients Forecast by Volume (2016-2025)
European Union Diagnosed HBV Patients Forecast by Volume (2016-2025)
European Union Treated HBV Patients Forecast by Volume (2016-2025)
Japan HBV Market Forecast by Value (2016-2025)
Global Ageing Population (2006-2015)
Global Healthcare Expenditure (2007-2015)
Global Urban Population (2007-2015)
Arrowhead’s Revenue and Net Income (2011-2015)
Arbutus Revenue and Net Income (2011-2015)
Gilead’s Revenues Share by Product Sales (2015)
Gilead’s Revenues and Net Income (2011-2015)
J&J’s Revenues Share by Product Sales (2015)
J&J’s Sales and Net Income (2011-2015)

Place a direct purchase order on this report at http://www.orbisresearch.com/contact/purchase/119098 . AND if you have enquire before buying this report visit at http://www.orbisresearch.com/contacts/enquiry-before-buying/119098 .

List of Tables
HBV Blood Tests and Indications
Chronic HBV Disease Phases
Global HBV Therapies in Development by Company
Global HBV Therapies in Development by Mechanism
Comparison of Anti-Sense Therapies by Company
Comparison of Core Inhibitors/CpAMs by Company

About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Media Contact
Company Name: Orbis Research
Contact Person: Hector Costello
Email: sales@orbisresearch.com
Phone: +1 (214) 884-6817
Address:4144N Central Expressway, Suite 600
City: Dallas
State: Texas
Country: United States
Website: http://www.orbisresearch.com/reports/index/global-hepatitis-b-virus-hbv-market-10-year-demand-forecast-2016-2025

Comments are closed.